Related Experiment Video
Updated: Apr 12, 2026

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
Published on: August 23, 2024
BRAF Mutation in Hairy Cell Leukemia
Ahmad Ahmadzadeh1, Saeid Shahrabi2, Kaveh Jaseb1
1Health Research Institute, Research Center of Thalassemia and Hemoglobinopathy, Ahvaz Jundishapur University of Medical Sciences , Ahvaz.
The BRAF V600E mutation is a key driver in hairy cell leukemia (HCL) pathogenesis. Identifying this mutation aids in differentiating HCL from other B-cell malignancies and suggests targeted BRAF inhibitor therapy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The mitogen-activated protein kinase (MAPK) pathway is crucial for cell regulation.
- Mutations in BRAF, a key kinase in the MAPK pathway, can lead to uncontrolled cell proliferation and cancer.
- Hairy cell leukemia (HCL) is a B-cell malignancy associated with specific genetic alterations.
Purpose of the Study:
- To review the role of BRAF gene mutations in the pathogenesis and progression of HCL.
- To highlight the significance of the BRAF V600E mutation as a diagnostic marker.
- To discuss potential therapeutic strategies targeting BRAF mutations in HCL.
Main Methods:
- Literature review of studies on BRAF mutations in HCL.
- Analysis of BRAF mutation status in various B-cell malignancies.
- Discussion of BRAF inhibitor efficacy and miRNA interactions within the MAPK pathway.
Main Results:
- The BRAF V600E mutation is highly prevalent in classic HCL but absent in HCL variants.
- This mutation serves as a reliable marker to distinguish between HCL subtypes.
- BRAF mutations are implicated in the uncontrolled cell division characteristic of HCL.
Conclusions:
- BRAF V600E mutation is a critical factor in HCL development.
- BRAF mutation analysis is valuable for differential diagnosis of B-cell disorders.
- Targeted therapies inhibiting BRAF protein show promise for HCL treatment.
Related Concept Videos
Abnormal Proliferation
The Ras Gene
Ras is a...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Multipotency and Niche of Bulge Stem Cell
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell

